Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:605016's Current Ratio is ranked better than 67.94% of 1996
companies
in the Consumer Packaged Goods industry
Industry Median: 1.73
vs SHSE:605016: 2.51
Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Shandong Bailong Chuangyuan Bio-Tech Co Current Ratio Related Terms
Shandong Bailong Chuangyuan Bio-Tech Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Bailong Chuangyuan Bio-Tech Co Current Ratio Chart
Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
For the Packaged Foods subindustry, Shandong Bailong Chuangyuan Bio-Tech Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Bailong Chuangyuan Bio-Tech Co Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Shandong Bailong Chuangyuan Bio-Tech Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Shandong Bailong Chuangyuan Bio-Tech Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) has a Current Ratio of 2.51 as of Mar. 2026. This is 14% below median its historical median of 2.91. Over the past decade, Shandong Bailong Chuangyuan Bio-Tech Co's Current Ratio has ranged from 1.24 to 11.68. According to the industry distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #640 out of 1996 companies in the Consumer Packaged Goods industry, placing it in the top 32.1%.
Is Shandong Bailong Chuangyuan Bio-Tech Co's Current Ratio too high?
Shandong Bailong Chuangyuan Bio-Tech Co's current Current Ratio of 2.51 is 14% below median its 10-year median of 2.91. Over the past 10 years, this metric has ranged from a low of 1.24 to a high of 11.68. The Consumer Packaged Goods industry median Current Ratio is 1.73. Shandong Bailong Chuangyuan Bio-Tech Co's value of 2.51 is 45.1% above this industry median. Based on the distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #640 out of 1996 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Shandong Bailong Chuangyuan Bio-Tech Co has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shandong Bailong Chuangyuan Bio-Tech Co's Current Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Shandong Bailong Chuangyuan Bio-Tech Co ranks #640 out of 1996 companies for Current Ratio. This puts Shandong Bailong Chuangyuan Bio-Tech Co in the upper half of its industry. The industry median Current Ratio is 1.73. Shandong Bailong Chuangyuan Bio-Tech Co's value of 2.51 is 45.1% above this benchmark. Historically, Shandong Bailong Chuangyuan Bio-Tech Co's own Current Ratio has ranged from 1.24 to 11.68 over the past decade. While the company's 10-year median is 2.91 vs. the industry median of 1.73, Shandong Bailong Chuangyuan Bio-Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,996 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Bailong Chuangyuan Bio-Tech Co's current Current Ratio of 2.51 is 45.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Bailong Chuangyuan Bio-Tech Co's current Current Ratio is 2.51, which is 14% below median its own 10-year median of 2.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Bailong Chuangyuan Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) is currently considered Fairly Valued. The stock's GF Value™ is ¥22.57, compared to a current price of ¥21.50 — trading 4.7% below its estimated fair value. The current Current Ratio is 2.51, which is 14% below median its 10-year median of 2.91 and 45.1% above the Consumer Packaged Goods industry median of 1.73. Shandong Bailong Chuangyuan Bio-Tech Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016), the current Current Ratio is 2.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co stock appears to be undervalued.
The current stock price of ¥21.50 is trading 4.7% below its estimated GF Value™ of ¥22.57.
GuruFocus considers Shandong Bailong Chuangyuan Bio-Tech Co to be Fairly Valued.
Key valuation signals for SHSE:605016:
Current Ratio: 2.51 (14% below median its 10-year median of 2.91)
GF Value™: ¥22.57 vs. price of ¥21.50 (4.7% below fair value)
Industry Position: 45.1% above the Consumer Packaged Goods median (#640 of 1996)
No single metric tells the full story. See the SHSE:605016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Bailong Chuangyuan Bio-Tech Co Business Description
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
96GF Score
Get the complete analysis for SHSE:605016
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605016 has been successfully added to your 
